GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) » Definitions » 3-Year Dividend Growth Rate

Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) 3-Year Dividend Growth Rate : -17.80% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co 3-Year Dividend Growth Rate?

Shenzhen Hepalink Pharmaceutical Group Co's Dividends per Share for the three months ended in Mar. 2024 was HK$0.00.

The historical rank and industry rank for Shenzhen Hepalink Pharmaceutical Group Co's 3-Year Dividend Growth Rate or its related term are showing as below:

HKSE:09989' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -46.8   Med: -20.6   Max: 49.4
Current: -17.8

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shenzhen Hepalink Pharmaceutical Group Co was 49.40% per year. The lowest was -46.80% per year. And the median was -20.60% per year.

HKSE:09989's 3-Year Dividend Growth Rate is ranked worse than
90.85% of 317 companies
in the Drug Manufacturers industry
Industry Median: 9.9 vs HKSE:09989: -17.80

During the past 12 months, Shenzhen Hepalink Pharmaceutical Group Co's average Dividends Per Share Growth Rate was 185.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -17.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 1.90% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Shenzhen Hepalink Pharmaceutical Group Co's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Shenzhen Hepalink Pharmaceutical Group Co's Dividend Yield % is 3.06%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Shenzhen Hepalink Pharmaceutical Group Co Ltd is 1.43, which seems too high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's 3-Year Dividend Growth Rate falls into.



Shenzhen Hepalink Pharmaceutical Group Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Shenzhen Hepalink Pharmaceutical Group Co  (HKSE:09989) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Shenzhen Hepalink Pharmaceutical Group Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 0.073
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 7.58. The lowest was 0.07. And the median was 0.44.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Shenzhen Hepalink Pharmaceutical Group Co Ltd is 1.43, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Shenzhen Hepalink Pharmaceutical Group Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.1121502023-05-242023-05-292023-08-15Cash DividendannuallyHKD:HKD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Shenzhen Hepalink Pharmaceutical Group Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.11215/3.66
=3.06 %

Current Share Price is HK$3.66.
Shenzhen Hepalink Pharmaceutical Group Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.11215.

During the past 13 years, the highest Dividend Yield of Shenzhen Hepalink Pharmaceutical Group Co was 3.54%. The lowest was 0.17%. And the median was 1.05%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Hepalink Pharmaceutical Group Co 3-Year Dividend Growth Rate Related Terms>


Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business and Others. Geographical presence of company is in Hong Kong, United States of America, Europe, Mainland China and Other countries. Majority of the company's revenue comes from USA and Europe.

Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Headlines

No Headlines